REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Israel, Austria, and Denmark will Partner to Develop Vaccines for Future Pandemics and Variants of COVID-19

Develop Vaccines for Future Pandemics and Variants of COVID-19
The trilateral pact includes investment in production plants in Europe and Israel in case of potential future pandemics.

Austrian Chancellor, Sebastian Kurz, and Danish Prime Minister, Mette Frederiksen, visited Israel and met with Israeli Prime Minister, Benjamin Netanyahu, to discuss a joint venture between the three countries. According to media reports, Austria and Denmark are displeased by the relatively slow rollout of COVID-19 vaccines in the European Union and decided to form a partnership with Israel to develop and produce second-generation vaccines against mutations of the coronavirus and future pandemics.

Israel leads the world in COVID-19 vaccinations per capita and has already inoculated more than 47% of its population. During a meeting with his counterparts, Prime Minister Netanyahu took pride in Israel’s “excellent” health services, pointing out that Sheba Medical Center was ranked one of the top 10 hospitals in the world. According to Netanyahu, “The local vaccine production initiative has galvanized the imagination of the world. We agreed that if other nations want to join us, we’ll discuss it among ourselves and welcome others to come.”

According to the three leaders, the partnership would involve setting up a research and development fund for future vaccines and investment in production plants in Europe and Israel. For his part, Chancellor Kurz explained: “We must prepare for further mutations and should no longer be dependent only on the EU for the production of second-generation vaccines.” Prime Minister Frederiksen added: “I don’t think the EU’s vaccine program can stand alone, because we need to increase capacity. That is why we are now fortunate to start a partnership with Israel… the three countries all have promising research that could pave the way for a next-generation platform”.

Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More